Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling-Reference-Cited by-同舟云学术

Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling

Published:2013-01-20 Issue:4 Volume:33 Page:561-568
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Reiberger Thomas¹,Payer Berit Anna¹,Schwabl Philipp¹,Hayden Hubert¹,Horvatits Thomas¹,Jäger Bernhard¹,Hummel Thomas¹,Mitterhauser Markus²,Trauner Michael¹,Fuhrmann Valentin¹,Angermayr Bernhard¹,Peck-Radosavljevic Markus¹,

Affiliation:

1. Department of Internal Medicine III; Division of Gastroenterology & Hepatology; Medical University of Vienna; Vienna Austria

2. Department of Nuclear Medicine; Medical University of Vienna; Vienna Austria

Funder

Austrian Society of Internal Medicine

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12101/fullpdf

Reference25 articles.

1. The global burden of hepatitis C;Lavanchy;Liver Int,2009

2. Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: a general population-based study;Fleming;J Hepatol,2008

3. Von willebrand factor as new non-invasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis;Ferlitsch;Hepatology,2012

4. Complications of cirrhosis. I. Portal hypertension;Bosch;J. Hepatol.,2000

5. Austrian consensus on the definition and treatment of portal hypertension and its complications;Peck-Radosavljevic;Endoscopy,2005

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADRENERGIC AGENTS IN CORRECTION OF PORTAL HYPERTENSION IN CIRRHOSIS OF THE LIVER;Hepatology and Gastroenterology;2020-06-04

2. Animal models of portal hypertension;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2019-05

3. Pericytes in the Gut;Advances in Experimental Medicine and Biology;2019

4. β-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial;European Journal of Gastroenterology & Hepatology;2018-08

5. Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats;Journal of Visualized Experiments;2018-08-01